StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report published on Thursday. The firm issued a buy rating on the stock. A number of other brokerages have also commented on MEIP. TheStreet cut shares of MEI Pharma from a c- rating to a d+ rating in a report on […]